IDEXX Laboratories, Inc.

IDXX Healthcare Diagnostics & Research

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.66%, EPS grew 17.2%, free cash flow grew 111.4% and total debt fell 14.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three.

560.36 13.18 +2.41%
Market cap
$43.1B
P/E
39.1×
Fwd P/E
38.3×
Dividend yield
—
F-score
8/9
Altman Z
24.09
Beneish M
−2.50
Dividend safety
n/a

IDEXX Laboratories, Inc. (IDXX) P/B ratio

Alert me on P/B ratio

As of 16 October 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/B ratio of 27.4×. Over the past ten years it has ranged from 0.0× (March 2019) to 859× (August 2015); the current reading is higher than 39% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 33.9× 58.59%
FY2024 21.4× (30.26%)
FY2023 30.6× (45.05%)
FY2022 55.8× (31.40%)
FY2021 81.3× 20.61%
FY2020 67.4× (46.69%)
FY2019 126× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/B ratio Change
Jun 2026 25.8× (10.38%)
Mar 2026 28.8× (15.15%)
Dec 2025 33.9× 3.40%
Sep 2025 32.8× 10.87%
42 more quarters

Against its own ten years

Low 0.0× High 859×
Ten-year median 34.4×
Current reading's percentile 18

P/B ratio against peers

Company P/B ratio
WAT Waters Corporation compare 2.8×
LH Labcorp Holdings Inc. compare 3.0×
DGX Quest Diagnostics Incorporated compare 3.3×
A Agilent Technologies, Inc. compare 6.6×
IQV IQVIA Holdings Inc. compare 7.0×
ILMN Illumina, Inc. compare 13.9×
IDXX IDEXX Laboratories, Inc. 27.4×
NTRA Natera, Inc. compare 30.8×
MTD Mettler-Toledo International, Inc. compare 2,546×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.3×
Market median 1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on IDXX